Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Cholib“
Suchtreffer
Begriffe & Kennungen
Cholib · 4.5 · Interacting substances Prescribing recommendations Potent CYP 3A4 inhibitors: Itraconazole Ketoconazole Flucon
Eintrag öffnenCholib · 4.5 · Interaction between simvastatin and fenofibrate Effects of repeated administration of fenofibrate on the pharm
Eintrag öffnenCholib · 4.5 · Interaction between simvastatin and fenofibrate Effects of repeated administration of fenofibrate on the pharm
Eintrag öffnenCholib · 4.5 · Interactions relevant to monotherapies Inhibitors of CYP 3A4 Simvastatin is a substrate of cytochrome P450 3A4
Eintrag öffnenCholib · 4.5 · Interactions relevant to monotherapies Inhibitors of CYP 3A4 Simvastatin is a substrate of cytochrome P450 3A4
Eintrag öffnenCholib · 4.5 · Multiple mechanisms may contribute to potential interactions with HMG Co-A reductase inhibitors. Drugs or herb
Eintrag öffnenCholib · 4.5 · Multiple mechanisms may contribute to potential interactions with HMG Co-A reductase inhibitors. Drugs or herb
Eintrag öffnenCholib · 4.5 · Niacin (nicotinic acid) Cases of myopathy/rhabdomyolysis have been associated with concomitant administration
Eintrag öffnenCholib · 4.5 · Niacin (nicotinic acid) Cases of myopathy/rhabdomyolysis have been associated with concomitant administration
Eintrag öffnenCholib · 4.5 · No interaction studies have been performed with Cholib.
Eintrag öffnenCholib · 4.5 · No interaction studies have been performed with Cholib.
Eintrag öffnenCholib · 4.5 · Other statins and fibrates Gemfibrozil increases the AUC of simvastatin acid by 1.9-fold, possibly due to inhi
Eintrag öffnenCholib · 4.5 · Other statins and fibrates Gemfibrozil increases the AUC of simvastatin acid by 1.9-fold, possibly due to inhi
Eintrag öffnenCholib · 4.5 · Patients receiving co-administration of Cholib and drugs metabolised by CYP 2C19, CYP 2A6, or especially CYP 2
Eintrag öffnenCholib · 4.5 · Physicians contemplating combined therapy with Cholib and lipid-modifying doses (≥ 1 g/day) of niacin (nicotin
Eintrag öffnenCholib · 4.5 · Physicians contemplating combined therapy with Cholib and lipid-modifying doses (≥ 1 g/day) of niacin (nicotin
Eintrag öffnenCholib · 4.5 · Potent inhibitors of cytochrome P450 3A4 increase the risk of myopathy and rhabdomyolysis by increasing the co
Eintrag öffnenCholib · 4.5 · Potent inhibitors of cytochrome P450 3A4 increase the risk of myopathy and rhabdomyolysis by increasing the co
Eintrag öffnenCholib · 4.5 · Prescribing recommendations for interacting substances are summarised in the table below (see also sections 4.
Eintrag öffnenCholib · 4.5 · Prescribing recommendations for interacting substances are summarised in the table below (see also sections 4.
Eintrag öffnen